Plasma Lipidomic Profiles Improve on Traditional Risk Factors for the Prediction of Cardiovascular Events in Type 2 Diabetes Mellitus
Zahir H Alshehry, Piyushkumar A Mundra, Christopher K Barlow, Natalie A Mellett, Gerard Wong, Malcolm J McConville, John Simes, Andrew M Tonkin, David R Sullivan, Elizabeth H Barnes, Paul J Nestel, Bronwyn A Kingwell, Michel Marre, Bruce Neal, Neil R Poulter, Anthony Rodgers, Bryan Williams, Sophia Zoungas, Graham S Hillis, John Chalmers Show all
Circulation | LIPPINCOTT WILLIAMS & WILKINS | Published : 2016
Awarded by National Health and Medical Research Council of Australia
Awarded by Medical Research Council
Awarded by National Institute for Health Research
The Action in Diabetes and Vascular Disease: Preterax and Diamicron-MR Controlled Evaluation trial was funded by the National Health and Medical Research Council of Australia (grants 211086 and 358395). The Long-Term Intervention With Pravastatin in Ischemic Disease trial was supported by a research grant from Bristol-Myers Squibb, Princeton, NJ, and was conducted independently of the sponsor under the auspices of the National Heart Foundation of Australia. This work was funded by the National Health and Medical Research Council of Australia (grant 1029754), the Operational Infrastructure Support Program of the Victorian Government, Australia, and King Fahad Medical City, Riyadh, Saudi Arabia.